How we treat Merkel cell carcinoma: Within and beyond current guidelines

  • Song Y. Park
  • , Coley Doolittle-Amieva
  • , Yasman Moshiri
  • , Tomoko Akaike
  • , Upendra Parvathaneni
  • , Shailender Bhatia
  • , Lisa C. Zaba
  • , Paul Nghiem

Research output: Contribution to journalReview articlepeer-review

29 Scopus citations

Abstract

Merkel cell carcinoma (MCC) is an aggressive skin cancer associated with a high risk of local recurrence and distant metastasis. Optimal care of this potentially life-threatening cancer is critical but challenging because: physicians are often unfamiliar with its management due to rarity, and MCC management remains controversial, in part because it is rapidly evolving across multiple specialties. While guidelines offer a broad overview of management, they are often not sufficient when making decisions for individual patients. Herein, we present a literature review as well as practical approaches adopted at our institutions for staging, surveillance and therapy of MCC. Each of these areas are discussed in light of how they can be appropriately customized for prevalent but challenging situations. We also provide representative examples of MCC patient scenarios and how they were managed by a multidisciplinary team to identify suitable evidence-based, individualized treatment plans.

Original languageEnglish (US)
Pages (from-to)1363-1377
Number of pages15
JournalFuture Oncology
Volume17
Issue number11
DOIs
StatePublished - Apr 2021
Externally publishedYes

Keywords

  • Merkel cell carcinoma
  • customized treatment
  • imaging
  • immunotherapy
  • multidisciplinary management
  • radiotherapy
  • surgery
  • surveillance

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint

Dive into the research topics of 'How we treat Merkel cell carcinoma: Within and beyond current guidelines'. Together they form a unique fingerprint.

Cite this